News
FTC disputes new slate of Orange Book patents for weight loss, diabetes, asthma, and COPD drugs
06 May 2024
On April 30, 2024, the Federal Trade Commission (FTC) announced that it sent a new set of warning letters to ten pharmaceutical companies. The letters inform the companies that the...